APA (7th ed.) Citation

Wakabayashi, H., Nagao, N., Inada, H., Nishioka, Y., Hasegawa, M., Nishioka, K., & Sudo, A. (2021). Long-Term Maintenance of Golimumab Effectiveness for Injection Spacing in Rheumatoid Arthritis Patients with Low Disease Activity Who Previously Received Other TNF Inhibitors: Minimum 2-year Data From an Observational Study. Drugs in R&D, 21(3), 351. https://doi.org/10.1007/s40268-021-00355-2

Chicago Style (17th ed.) Citation

Wakabayashi, Hiroki, Nobuto Nagao, Hitoshi Inada, Yosuke Nishioka, Masahiro Hasegawa, Kusuki Nishioka, and Akihiro Sudo. "Long-Term Maintenance of Golimumab Effectiveness for Injection Spacing in Rheumatoid Arthritis Patients with Low Disease Activity Who Previously Received Other TNF Inhibitors: Minimum 2-year Data From an Observational Study." Drugs in R&D 21, no. 3 (2021): 351. https://doi.org/10.1007/s40268-021-00355-2.

MLA (9th ed.) Citation

Wakabayashi, Hiroki, et al. "Long-Term Maintenance of Golimumab Effectiveness for Injection Spacing in Rheumatoid Arthritis Patients with Low Disease Activity Who Previously Received Other TNF Inhibitors: Minimum 2-year Data From an Observational Study." Drugs in R&D, vol. 21, no. 3, 2021, p. 351, https://doi.org/10.1007/s40268-021-00355-2.